Nephrology Department, Hannover Medical School, Hannover, Germany.
Phenos GmbH, Hannover, Germany.
Front Immunol. 2020 Dec 9;11:573550. doi: 10.3389/fimmu.2020.573550. eCollection 2020.
GPI-anchored uPAR is the receptor for the extracellular serine protease urokinase-type plasminogen activator (uPA). Though uPAR role in inflammatory processes is documented, underlying mechanisms are not fully understood. In this study we demonstrate that uPAR is a part of Toll-like receptor 4 (TLR4) interactome. Downregulation of uPAR expression resulted in diminished LPS-induced TLR4 signaling, less activation of NFκB, and decreased secretion of inflammatory mediators in myeloid and non-myeloid cells . In vivo uPAR-/- mice demonstrated better survival, strongly diminished inflammatory response and better organ functions in cecal ligation and puncture mouse polymicrobial sepsis model. Mechanistically, GPI-uPAR and soluble uPAR colocalized with TLR4 on the cell membrane and interacted with scavenger receptor CD36. Our data show that uPAR can interfere with innate immunity response TLR4 and this mechanism represents a potentially important target in inflammation and sepsis therapy.
GPI-锚定型 uPAR 是细胞外丝氨酸蛋白酶尿激酶型纤溶酶原激活物 (uPA) 的受体。尽管 uPAR 在炎症过程中的作用已有文献记载,但潜在的机制尚不完全清楚。在这项研究中,我们证明了 uPAR 是 Toll 样受体 4 (TLR4) 相互作用组的一部分。下调 uPAR 的表达导致 LPS 诱导的 TLR4 信号减弱,NFκB 的激活减少,以及髓系和非髓系细胞中炎症介质的分泌减少。体内 uPAR-/- 小鼠在盲肠结扎和穿刺小鼠多微生物脓毒症模型中表现出更好的生存能力、炎症反应明显减弱和器官功能更好。从机制上讲,GPI-uPAR 和可溶性 uPAR 与 TLR4 在细胞膜上共定位,并与清道夫受体 CD36 相互作用。我们的数据表明,uPAR 可以干扰先天免疫反应 TLR4,这种机制代表了炎症和脓毒症治疗中一个潜在的重要靶点。